MARIA CASTILLO: Open Payments
NPI 1184924144 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 11 payments from 7 companies in 2025. Trend: 2023 $888 · 2024 $140 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $104 |
| Novo Nordisk Inc | 2 | $44 |
| RedHill Biopharma Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $32 |
| Amgen Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Korlym, Talicia, MOUNJARO, OTEZLA, Wegovy, JARDIANCE, BREZTRI.
Industry payments across CA — which companies pay providers there.
